Viridian Therapeutics Inc... (VRDN)
NASDAQ: VRDN
· Real-Time Price · USD
18.53
0.09 (0.49%)
At close: Aug 15, 2025, 3:59 PM
18.50
-0.16%
After-hours: Aug 15, 2025, 07:26 PM EDT
Viridian Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 117.32M | 116.22M | 99.59M | 200.32M | 107.67M | 91.64M | 102.83M | 111.6M | 87.08M | 88.52M | 155.58M | 344.21M | 31.29M | 30.86M | 42.3M | 138.88M | 27.7M | 46.49M |
Short-Term Investments | 446.03M | 520.42M | 617.99M | 552.92M | 463.7M | 521.55M | 374.54M | 201.41M | 247.21M | 285.34M | 268.97M | 87.11M | 129.91M | 144.57M | 154.67M | 74.94M | 81.6M | 70.61M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 506K | 489K | 501K | 853K | 659K | 555K | 604K | 1.26M | 1.18M | 9.73M | 7.61M | 1.15M | 1.51M | 1.54M | 1.49M | 1.46M | 875K | 778K |
Receivables | n/a | n/a | n/a | 14K | n/a | 102K | 102K | 102K | 102K | 128K | 102K | 398K | 693K | 522K | 451K | 479K | 2.05M | 1.38M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.74M | -6.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 15.39M | 20.61M | 20.88M | 14.1M | 10.3M | 13.53M | 9.01M | 10.73M | 11.94M | 8.62M | 6.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 578.75M | 657.24M | 738.46M | 767.36M | 581.66M | 626.82M | 486.48M | 323.84M | 346.33M | 373.86M | 424.55M | 437.36M | 166.15M | 179.39M | 200.16M | 217.94M | 115.46M | 121.53M |
Property-Plant & Equipment | 3.07M | 3.25M | 3.44M | 3.69M | 3.34M | 3.01M | 3.34M | 3.65M | 3.95M | 3.06M | 2.94M | 2.07M | 2.15M | 2.23M | 2.06M | 1.81M | 1.86M | 520K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 3.57M | 3.74M | 3.94M | 4.54M | 4M | 3.56M | 3.95M | 4.92M | 5.14M | 12.78M | 10.54M | 3.23M | 3.66M | 3.78M | 3.55M | 3.27M | 2.74M | 1.3M |
Total Assets | 582.32M | 660.98M | 742.4M | 771.9M | 585.66M | 630.38M | 490.42M | 328.76M | 351.47M | 386.64M | 435.09M | 440.58M | 169.81M | 183.16M | 203.71M | 221.21M | 118.2M | 122.83M |
Account Payables | 8.52M | 3.89M | 2.14M | 6.34M | 3.14M | 2.68M | 2.24M | 3.73M | 4.13M | 7.87M | 14.23M | 12.15M | 4.06M | 2.54M | 2.33M | 3.73M | 2.39M | 3.38M |
Deferred Revenue | 288K | 288K | 288K | 288K | 288K | 288K | 288K | 288K | 288K | 288K | 288K | 288K | 288K | 288K | 289K | 288K | 288K | 288K |
Short-Term Debt | 8.44M | n/a | n/a | n/a | 2.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 8.19M | 5.2M | 10.74M | 34.15M | 20.83M | 15.37M | 12.75M | 10.76M | 17.76M | 17.23M | 4.87M | 3.68M | 13.88M | 9.43M | 6.85M | 7.54M | 11.17M | 9.69M |
Total Current Liabilities | 52.59M | 33.73M | 47.87M | 41.36M | 36.76M | 26.13M | 26.64M | 23.25M | 28.66M | 29.59M | 33.35M | 25.21M | 21.39M | 14.39M | 13.64M | 14.34M | 16.83M | 16.44M |
Long-Term Debt | 12.35M | 20.68M | 20.58M | 20.52M | 17.49M | 20.33M | 20.2M | 20M | 4.71M | 4.68M | 4.64M | 4.61M | 4.58M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 2.08M | 1.88M | 2.02M | 2.52M | 1.65M | n/a | 989K | 1.29M | 1.53M | 1.04M | 1.17M | 813K | 938K | 1.06M | 1.21M | 2.27M | 2.46M | 398K |
Total Long-Term Liabilities | 14.57M | 22.78M | 22.89M | 23.04M | 19.56M | 21.72M | 21.77M | 21.93M | 6.95M | 6.5M | 6.68M | 6.36M | 6.53M | 2.14M | 2.36M | 2.27M | 2.46M | 398K |
Total Liabilities | 67.16M | 56.51M | 70.76M | 64.4M | 56.33M | 47.85M | 48.4M | 45.18M | 35.61M | 36.09M | 40.03M | 31.57M | 27.92M | 16.52M | 15.99M | 16.61M | 19.29M | 16.83M |
Total Debt | 21.34M | 21.22M | 21.09M | 21.11M | 20.96M | 21.96M | 21.05M | 20.82M | 5.51M | 5.31M | 5.26M | 5.18M | 5.17M | 579K | 520K | 430K | 412K | 355K |
Common Stock | 817K | 816K | 810K | 792K | 639K | 638K | 540K | 437K | 436K | 431K | 414K | 402K | 285K | 272K | 239K | 194K | 86K | 72K |
Retained Earnings | -1.18B | -1.08B | -995.86M | -916.13M | -839.44M | -774.45M | -725.91M | -659.05M | -611.39M | -556.33M | -488.17M | -442.39M | -413.48M | -383.99M | -358.3M | -329.35M | -315.31M | -297.35M |
Comprehensive Income | 69K | n/a | -10K | n/a | -543K | -367K | 338K | -64K | -173K | -174K | -390K | -940K | -1.08M | -935K | -157K | -3K | -12K | -21K |
Shareholders Equity | 515.17M | 604.47M | 671.64M | 707.5M | 529.34M | 582.53M | 442.02M | 283.58M | 315.86M | 350.55M | 395.06M | 409.01M | 141.9M | 166.64M | 187.72M | 204.59M | 98.91M | 106M |
Total Investments | 446.03M | 520.42M | 617.99M | 552.92M | 463.7M | 521.55M | 374.54M | 201.41M | 247.21M | 285.34M | 268.97M | 87.11M | 129.91M | 144.57M | 154.67M | 74.94M | 81.6M | 70.61M |